Andrew Meslow

Executive

Chairman & CEO

Bath & Body Works, Inc.Vera Bradley, Inc.

Insider activity · 24 months2 buys0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 1 buy · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 1 buy · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (2 ops.)

€830k

▼ Sales (0 ops.)

—

Latest filing published 07 Apr 2026 for Vera Bradley, Inc.. Read the official filing

Filing timeline

BuySale

Andrew Meslow

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

50%

T+90 mean return

+21.8%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Andrew Meslow: trading record in brief

Andrew Meslow, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Vera Bradley, Inc. and Bath & Body Works, Inc. Between 28 March 2022 and 3 April 2026, the trades on record add up to 6 filings.

On the market, this insider has only ever bought: 2 purchases, €830k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants.

The latest filing, published on 7 April 2026, reports a share grant in Vera Bradley, Inc. The clock since the last published purchase (15 December 2025) now reads 307 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.